Elevance Health, Inc. (LON:0HG8)
London
· Delayed Price · Currency is GBP · Price in USD 382.35
-0.94 (-0.25%)
At close: Jun 5, 2025
Elevance Health Revenue
Elevance Health had revenue of $48.89B USD in the quarter ending March 31, 2025, with 14.83% growth. This brings the company's revenue in the last twelve months to $183.12B, up 6.63% year-over-year. In the year 2024, Elevance Health had annual revenue of $176.81B with 3.19% growth.
Revenue (ttm)
$183.12B
Revenue Growth
+6.63%
P/S Ratio
0.46
Revenue / Employee
$1.76M
Employees
104,200
Market Cap
65.71B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 176.81B | 5.47B | 3.19% |
| Dec 31, 2023 | 171.34B | 14.74B | 9.41% |
| Dec 31, 2022 | 156.60B | 17.96B | 12.95% |
| Dec 31, 2021 | 138.64B | 16.78B | 13.76% |
| Dec 31, 2020 | 121.87B | 17.66B | 16.94% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 42.56B |
| GSK plc | 31.53B |
| Haleon | 11.23B |
| Smith & Nephew | 4.64B |
| ConvaTec Group | 1.83B |
| Hikma Pharmaceuticals | 2.50B |
| HUTCHMED (China) | 503.39M |
| Genus | 671.60M |
Elevance Health News
- 11 days ago - ROSEN, SKILLED INVESTOR COUNSEL, Encourages Elevance Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ELV - Accesswire
- 11 days ago - INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Elevance Health, Inc. of Class Action Lawsuit and Upcoming Deadlines - ELV - PRNewsWire
- 11 days ago - ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Elevance Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ELV - GlobeNewsWire
- 11 days ago - ELV SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Elevance Health, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit! - Accesswire
- 12 days ago - ELV INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Elevance Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - PRNewsWire
- 12 days ago - ELV FRAUD: Suffer Losses on Elevance Health, Inc.? You may have been Affected by Fraud and are Urged to Contact BFA Law (NYSE:ELV) - GlobeNewsWire
- 12 days ago - ELV INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Elevance Health, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit! - Accesswire
- 13 days ago - INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Elevance Health, Inc. of Class Action Lawsuit and Upcoming Deadlines - ELV - Accesswire